FAKTOR-OPTIONSSCHEIN - INCYTE CO. Stock

DE000SD416T4

Market Closed - Bid/Ask 03:36:56 2024-05-17 pm EDT			After market 03:59:57 pm
5.19 ^EUR	-2.08%		5.23	+0.77%

Current month	-39.49%
1 month	-34.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	May. 15
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	May. 14	BU
Equities Close Mixed as Markets Weigh Consumer Inflation Survey	May. 13	MT
Equities Close Mixed as Markets Parse Consumer Inflation Survey	May. 13	MT

More news

Quotes 5-day view

Date	Price	Change
24-05-17	5.19	-2.08%
24-05-16	5.3	+2.32%
24-05-15	5.18	-0.38%
24-05-14	5.2	+1.76%
24-05-13	5.11	-33.38%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 03:36 pm EDT

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SD416T
ISIN	DE000SD416T4
Date issued	2021-03-29
Strike	79.94 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.47 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	16.19 €
Lowest since issue	1.85 €
Spread	0.02 €
Spread %	0.38%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

56.86 USD

Average target price

73.35 USD

Spread / Average Target

+29.00%

Consensus